Want to join the ABTA virtual 50 mile Facebook Challenge? Check it out here.
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
This fall, join the brain tumor community for a BT5K Run & Walk and raise crucial funds for research!
Did you know 25% of lung cancer patients develop brain metastases? Get a look at the facts ahead of Lung Cancer Awareness Month.
You probably already know that GBM is a vicious, deadly disease. The question we all have is, what are we going to do about it? As we approach the fourth annual GBM Awareness Day on July 20, 2022, we’re asking you to get involved.
Go behind the scenes of the nation’s largest brain tumor conference and hear why the co-chairs say you don’t want to miss this year’s event, Sept. 9-10!
Dr. Duane Mitchell, MD, PhD, Univ. of Florida, shares four highlights in recent GBM research and what he’s hopeful for in the future.
**Sponsored Content**
Referred to as the “center point of progress in modern oncology,” biomarker testing opens up a world of targeted therapies that can guide an oncology treatment plan and turn more patients into survivors.
Read three takeaways from the American Association for Cancer Research annual meeting in April.
Engage with your community and learn about the latest treatment advances at the ABTA National Conference, September 9-10.
An upcoming webinar, presented in partnership with Living Beyond Breast Cancer, builds awareness of brain metastasis risks and treatment options for breast cancer patients.
Always free for patients & caregivers
The need for better brain tumor treatments and more help for patients is greater than ever. Brain tumors are still very hard to treat because of something called the blood-brain barrier, which makes it tough for medicine to reach the tumor. Brain tumor patients need more options.
That’s why we’re meeting hope head on—because donations lead to research, research leads to better treatments, and better treatments bring us closer to a cure.
